Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland)

Naloxone Hydrochloride, the active ingredient in Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland), is an opioid antagonist presented as an injectable solution for intramuscular, intravenous, subcutaneous use. It reverses opioid overdose effects in adults and children.

GNH USA supplies Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland) as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone Hydrochloride is an opioid antagonist used in the management of opioid toxicity.

- Opioid overdose: rapid reversal of respiratory depression and sedation. - Opioid‑induced respiratory depression: restoration of normal breathing. - Post‑operative opioid sedation: counteracts excessive sedation caused by opioid analgesics.

Naloxone Hydrochloride may be associated with a range of adverse reactions, most of which are transient.

Common Side Effects: - Nausea: mild stomach upset that resolves quickly. - Vomiting: occasional emesis following administration. - Sweating: increased perspiration. - Flushing: transient redness of the skin. - Tremor: mild shaking. - Headache: brief headache episodes.

Serious or Rare Side Effects: - Acute hypertension: sudden rise in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Seizure: rare convulsive episode. - Pulmonary edema: fluid accumulation in lungs. - Allergic reaction: rash, itching, or anaphylaxis.

When using Naloxone Hydrochloride, several precautions should be observed to ensure safety and effectiveness.

- Verify indication: confirm opioid overdose before administration. - Monitor response: observe patient for improvement in breathing and consciousness. - Re‑dose if needed: be prepared to repeat dose if opioid effect persists. - Avoid intravascular injection: ensure proper intramuscular, subcutaneous, or intravenous technique. - Document administration: record dose, time, and route in the patient chart. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone Hydrochloride can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Opioid agonists: concurrent use may diminish reversal effect. - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Tricyclic antidepressants: potential for severe hypertension.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may mask withdrawal symptoms; monitor sedation level. - Central nervous system depressants: combined effect on respiration; observe closely. - Sympathomimetic agents: possible additive cardiovascular effects.